• Home
  • Features
    • Adjuvant Tools
    • Formulas
    • Prognostic Scores
    • Common Toxicity Criteria for Adverse Events V5 & V4
    • AJCC TNM Staging
    • Drug Info
    • Drug Interaction Checker
  • Instructions For Use
  • Advertise With Us
  • FAQ’s
  • Contact
  • Log In
  • Sign Up
  • Home
  • Features
    • Adjuvant Tools
    • Formulas
    • Prognostic Scores
    • Common Toxicity Criteria for Adverse Events V5 & V4
    • AJCC TNM Staging
    • Drug Info
    • Drug Interaction Checker
  • Instructions For Use
  • Advertise With Us
  • FAQ’s
  • Contact
  • Log In
  • Sign Up

Weekly Oncology Highlights | Oncology News, Updates and Spotlights

by Dr. Suleka AR | Aug 8, 2025 | EU approvals, FDA approvals, News, Oncology news, Oncology Updates

[et_pb_text content_tablet=”Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies...

Weekly Oncology Highlights | Oncology News, Updates and Spotlights

by Dr. Suleka AR | Aug 1, 2025 | EU approvals, FDA approvals, News, Oncology news, Oncology Updates

[et_pb_text content_tablet=”Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies...

Weekly Oncology Highlights | Oncology News, Updates and Spotlights

by Dr. Suleka AR | Jul 25, 2025 | EU approvals, FDA approvals, News, Oncology news, Oncology Updates

[et_pb_text content_tablet=”Your go-to digest for the latest breakthroughs in cancer care. From breakthrough PARP/AR combo efficacy to transformative immunotherapy approvals and rare cancer strides, this week’s oncology updates spotlight how precision therapies...

COMPANY

About

Features

How does ONCOasist generate revenue

Projects

Get in Touch

Instructions for use

QUICK LINKS

Blog

Contact Us

Mission Statement

Privacy Policy

Cookie Policy

Site Map

 

DOWNLOAD ONCOassist NOW

Join our global community

SUPPORTED BY

© 2026 ONCOassist. All Rights Reserved. ONCOASSIST is a registered trademark in the Republic of Ireland, the United Kingdom and the United States. Site: www.thegraphicseffect.com

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}